Journal Club: Psilocybin as Treatment for Anxiety & Depression in Terminal Cancer Patients

Join Editor-in-Chief Dr. Tyler Kjorvestad, Editor-at-Large Dr.
Gershom Hernandez, and Associate Editor Dr. Tony Ceman of The
Journal of Psychedelic Psychiatry as they review the literature
on the use of Psilocybin for the treatment of anxiety and
depression in terminally ill cancer patients. 


Articles:


Rapid and sustained symptom reduction following psilocybin
treatment for anxiety and depression in patients with
life-threatening cancer: a randomized controlled trial.


https://www.ncbi.nlm.nih.gov/pubmed/27909164 


Psilocybin produces substantial and sustained decreases in
depression and anxiety in patients with life-threatening cancer:
A randomized double-blind trial.


https://www.ncbi.nlm.nih.gov/pubmed/27909165


Have an article you would like to be reviewed for potential
publication or an article you would like us to discuss during the
next Journal Club podcast? Send us an email at
journalofpsychedelicpsychitary@gmail.com 


Follow us:


Website: https://www.journalofpsychedelicpsychiatry.org/


Twitter: https://twitter.com/psychedelic_org


Facebook:
https://www.facebook.com/JournalofPsychedelicPsychiatry/


Instagram:
https://www.instagram.com/journalpsychedelicpsychiatry/